Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy

Authors:

Abstract
No abstract available
Funding Information
  • University of California Davis Health System Vision (FL16MCX)
  • Bayer Pharma AG Grants4Targets (2014-08-1145)

This publication has 27 references indexed in Scilit: